Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Angel investors are raising the bar with tighter criteria, backing strong teams, realistic markets and clear paths to exit ...
NEW YORK, NY, UNITED STATES, April 7, 2026 /EINPresswire.com/ — Sigma Biotech Consulting, a New York City–based biotech consulting firm, today announced its ...
Entrepreneur and politician Vivek Ramaswamy made much of his fortune founding biotechnology companies and trading their stocks, but now the former GOP presidential candidate and current contender for ...
Stocktwits on MSN
SLS stock kicks off week in green: CEO flags role in EU biotech policy talks that could impact drug approvals
The CEO called the talks “exceptionally constructive” and said the engagement was a “meaningful recognition” of the company’s work. ・Investor focus remains on the Phase 3 Regal trial evaluating GPS ...
So, the natural question for Western Mines Group shareholders is whether they should be concerned by its rate of cash burn.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results